<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1010222699
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2013
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        ZITHROMAX 200MG-5ML SUSP.AFTER RECONSTIT
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        AZITHROMYCIN
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        40
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg/ml
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Powder for oral suspension
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        22
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bottle
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        do not store above 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        43.60
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="PFIZER SAUDI LIMITED" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            PFIZER SAUDI LIMITED
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 583]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            ALNAGHI COMPANY
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            PFIZER SAUDI LIMITED
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J01FA10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>This medicine contains azithromycin, which is one of a group of antibiotics called macrolides. It is used to treat infections caused by certain bacteria and other micro-organisms which include:</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; chest, throat or nasal infections (such as bronchitis, pneumonia, tonsillitis, sore throat (pharyngitis) and sinusitis)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; ear infections</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; skin and soft tissue infections (such as an abscess or boil)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; sexually-transmitted diseases caused by organisms called <em>Chlamydia trachomatis</em> or <em>Neisseria gonorrhoea</em>.</p><p>&nbsp;</p><p>You must talk to a doctor if you do not feel better or if you feel worse.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take Zithromax:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; if you/your child are allergic to azithromycin or any other macrolide antibiotic such as erythromycin or clarithromycin or any of the ingredients listed in section 6. An allergic reaction may cause skin rash or wheezing.</p><p>&nbsp;</p><p><strong>Warnings and precautions</strong></p><p>Talk to your doctor or pharmacist before taking Zithromax if you/your child have or have had any of the following:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; kidney problems</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; heart conditions</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; diabetes</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; liver problems: your doctor may need to monitor your liver function or stop the treatment</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; myasthenia gravis (a condition that causes certain muscles to become weak)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; or if you are taking any ergot derivatives such as ergotamine (used to treat migraine) as these medicines should not be taken together with Zithromax.</p><p>&nbsp;</p><p>Tell your doctor immediately if you feel your heart beating in your chest or have an abnormal heartbeat, or get dizzy or faint or suffer from any muscle weakness when taking Zithromax.</p><p>&nbsp;</p><p>If you develop diarrhoea or loose stools during or after treatment, tell your doctor at once. Do not take any medicine to treat your diarrhoea without first checking with your doctor. If your diarrhoea continues, please inform your doctor.</p><p>&nbsp;</p><p><strong>Other medicines and Zithromax</strong></p><p>Tell your doctor or pharmacist if you/your child are taking, have recently taken or might take any other medicines.</p><p>&nbsp;</p><p>In particular, Zithromax may interact with the medicines listed below:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; ergot or ergotamine, see &lsquo;Warnings and precautions&rsquo; section</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; warfarin or any similar medicine to prevent blood clots</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; ciclosporin (used to suppress the immune system to prevent and treat rejection of a transplanted organ or bone marrow)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; antacids (for indigestion)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; digoxin (used to treat heart failure)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; colchicine (used for gout and familial Mediterranean fever)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; terfenadine (for hay fever or a skin allergy)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; hydroxychloroquine or chloroquine (used to treat autoimmune diseases including rheumatoid arthritis, or to treat or prevent malaria): Taking these medicines at the same time as azithromycin may increase the chance of you getting side effects that affect your heart.</p><p>&nbsp;</p><p><strong>Zithromax with food and drink</strong></p><p>Please refer to section 3.</p><p>&nbsp;</p><p><strong>Pregnancy, breast-feeding and fertility</strong></p><p>If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.</p><p>&nbsp;</p><p><strong>Driving and using machines</strong></p><p>Zithromax is not expected to affect your ability to drive or use machines.</p><p>&nbsp;</p><p><strong>Zithromax suspension contains sucrose</strong>, a type of sugar. If you have been told by your doctor that you have an intolerance to some sugars contact your doctor before taking this medicine. If you are diabetic, you may need to take this into account in your diet.</p><p>&nbsp;</p><p><strong>Information on sodium content</strong></p><p>Zithromax contains less than 1 mmol sodium (23 mg) per 5 ml of reconstituted suspension, that is to say essentially &lsquo;sodium free&rsquo;.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take Zithromax:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; if you/your child are allergic to azithromycin or any other macrolide antibiotic such as erythromycin or clarithromycin or any of the ingredients listed in section 6. An allergic reaction may cause skin rash or wheezing.</p><p>&nbsp;</p><p><strong>Warnings and precautions</strong></p><p>Talk to your doctor or pharmacist before taking Zithromax if you/your child have or have had any of the following:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; kidney problems</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; heart conditions</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; diabetes</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; liver problems: your doctor may need to monitor your liver function or stop the treatment</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; myasthenia gravis (a condition that causes certain muscles to become weak)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; or if you are taking any ergot derivatives such as ergotamine (used to treat migraine) as these medicines should not be taken together with Zithromax.</p><p>&nbsp;</p><p>Tell your doctor immediately if you feel your heart beating in your chest or have an abnormal heartbeat, or get dizzy or faint or suffer from any muscle weakness when taking Zithromax.</p><p>&nbsp;</p><p>If you develop diarrhoea or loose stools during or after treatment, tell your doctor at once. Do not take any medicine to treat your diarrhoea without first checking with your doctor. If your diarrhoea continues, please inform your doctor.</p><p>&nbsp;</p><p><strong>Other medicines and Zithromax</strong></p><p>Tell your doctor or pharmacist if you/your child are taking, have recently taken or might take any other medicines.</p><p>&nbsp;</p><p>In particular, Zithromax may interact with the medicines listed below:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; ergot or ergotamine, see &lsquo;Warnings and precautions&rsquo; section</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; warfarin or any similar medicine to prevent blood clots</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; ciclosporin (used to suppress the immune system to prevent and treat rejection of a transplanted organ or bone marrow)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; antacids (for indigestion)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; digoxin (used to treat heart failure)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; colchicine (used for gout and familial Mediterranean fever)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; terfenadine (for hay fever or a skin allergy)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; hydroxychloroquine or chloroquine (used to treat autoimmune diseases including rheumatoid arthritis, or to treat or prevent malaria): Taking these medicines at the same time as azithromycin may increase the chance of you getting side effects that affect your heart.</p><p>&nbsp;</p><p><strong>Zithromax with food and drink</strong></p><p>Please refer to section 3.</p><p>&nbsp;</p><p><strong>Pregnancy, breast-feeding and fertility</strong></p><p>If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.</p><p>&nbsp;</p><p><strong>Driving and using machines</strong></p><p>Zithromax is not expected to affect your ability to drive or use machines.</p><p>&nbsp;</p><p><strong>Zithromax suspension contains sucrose</strong>, a type of sugar. If you have been told by your doctor that you have an intolerance to some sugars contact your doctor before taking this medicine. If you are diabetic, you may need to take this into account in your diet.</p><p>&nbsp;</p><p><strong>Information on sodium content</strong></p><p>Zithromax contains less than 1 mmol sodium (23 mg) per 5 ml of reconstituted suspension, that is to say essentially &lsquo;sodium free&rsquo;.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects although not everybody gets them.</p><p>&nbsp;</p><p><strong>Tell your doctor immediately if you experience any of the following symptoms after taking this medicine as the symptoms can be severe. </strong></p><p><strong>&nbsp;</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; sudden wheeziness, difficulty in breathing, swelling of eyelids, face or lips, rash or itching (especially affecting the whole body)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; severe or prolonged diarrhoea, which may have blood or mucus in it, during or after treatment with Zithromax as this may be a sign of serious bowel inflammation</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; severe skin rash causing redness and flaking</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; rapid or irregular heartbeat</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; low blood pressure</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Serious skin reactions:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; blistering of the skin, mouth, eyes and genitals (Stevens-Johnson Syndrome (SJS))</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; blistering of the skin, severe skin reaction (Toxic Epidermal Necrosis (TEN))</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; skin rash accompanied by other symptoms such as fever, swollen glands and an increase of eosinophils (a type of white blood cell). A rash appears as small, itchy red bumps (Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS))</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; skin eruption that is characterised by the rapid appearance of areas of red skin studded with small pustules (small blisters filled with white/yellow fluid) (Acute Generalized Exanthematous Pustulosis (AGEP)).</p><p>&nbsp;</p><p>Stop taking azithromycin if you develop these skin symptoms and contact your doctor or seek medical attention immediately.</p><p>&nbsp;</p><p>The most common side effects that occur when taking Zithromax are listed below. These may go away during treatment as your body adjusts to the medicine. Tell your doctor if any of these side effects continue to bother you:</p><p><strong>&nbsp;</strong></p><p><strong>Very common: may affect more than 1 in 10 people</strong></p><p>&bull; stomach cramps, feeling sick, diarrhoea, wind.</p><p>&nbsp;</p><p><strong>Common: may affect up to 1 in 10 people</strong></p><p>&bull; dizziness, headache</p><p>&bull; numbness or pins and needles</p><p>&bull; being sick, indigestion</p><p>&bull; loss of appetite, taste disturbance</p><p>&bull; visual disturbances, deafness</p><p>&bull; skin rash and /or itching</p><p>&bull; joint pain</p><p>&bull; low numbers of lymphocytes (a type of white blood cell), higher number of eosinophils (type of white blood cells)</p><p>&bull; low blood bicarbonate</p><p>&bull; tiredness or weakness.</p><p>&nbsp;</p><p><strong>Uncommon: may affect up to 1 in 100 people </strong></p><p>&bull; yeast infections of the mouth and vagina (thrush)</p><p>&bull; low numbers of leukocytes (a type of white blood cell), low number of neutrophils (a type of white blood cell)</p><p>&bull; allergic reactions of various severity</p><p>&bull; skin more sensitive to sunlight than normal</p><p>&bull; feeling nervous</p><p>&bull; reduced sense of touch or sensation (hypoesthesia)</p><p>&bull; sleepiness or sleeplessness (insomnia)</p><p>&bull; poor hearing or ringing in the ears</p><p>&bull; heart palpitations, chest pain</p><p>&bull; constipation, stomach pain associated with diarrhoea and fever</p><p>&bull; inflammation of the liver (hepatitis), changes in liver enzymes.</p><p>&bull; general loss of strength</p><p>&bull; swelling</p><p>&bull; general discomfort</p><p>&bull; abnormal laboratory test values (e.g. blood or liver tests).</p><p>&nbsp;</p><p><strong>Rare: may affect up to 1 in 1,000 people</strong></p><p>&bull; agitation</p><p>&bull; vertigo</p><p>&bull; changes in liver function</p><p>&nbsp;</p><p><strong>Not known: frequency cannot be estimated from the available data</strong></p><p>&bull; fits or fainting</p><p>&bull; aggression or anxiety</p><p>&bull; feeling hyperactive</p><p>&bull; localised muscle weakness</p><p>&bull; loss of smell or altered sense of smell, loss of taste</p><p>&bull; tongue discolouration</p><p>&bull; inflammation of the pancreas (pancreatitis)</p><p>&bull; inflammation of the kidney or kidney failure</p><p>&bull; yellowing of the skin or eyes (jaundice) or liver failure (rarely life-threatening)</p><p>&bull; bruising or prolonged bleeding after injury</p><p>&bull; abnormal electrocardiogram (ECG)</p><p>&bull; reduction in red blood cells which can make the skin pale and cause weakness or breathlessness.</p><p><strong>&nbsp;</strong></p><p><strong>Reporting of side effects</strong></p><p>If you get any&nbsp;side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system. By reporting side effects you can help provide more information on the safety of this medicine.</p><p><strong>&nbsp;</strong></p><p><strong>To Report side effects </strong></p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Saudi Arabia</strong></p><p><strong>&nbsp;</strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>National Pharmacovigilance Centre (NPC)</strong></p><ul><li>Call center: 19999</li><li>E-mail: npc.drug@sfda.gov.sa</li><li>Website: https://ade.sfda.gov.sa/&nbsp;&nbsp;</li></ul></td></tr></tbody></table><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Other</strong><strong> GCC States</strong></p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>-&nbsp;&nbsp; <em>Please contact the relevant competent authority.</em></p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects although not everybody gets them.</p><p>&nbsp;</p><p><strong>Tell your doctor immediately if you experience any of the following symptoms after taking this medicine as the symptoms can be severe. </strong></p><p><strong>&nbsp;</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; sudden wheeziness, difficulty in breathing, swelling of eyelids, face or lips, rash or itching (especially affecting the whole body)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; severe or prolonged diarrhoea, which may have blood or mucus in it, during or after treatment with Zithromax as this may be a sign of serious bowel inflammation</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; severe skin rash causing redness and flaking</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; rapid or irregular heartbeat</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; low blood pressure</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Serious skin reactions:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; blistering of the skin, mouth, eyes and genitals (Stevens-Johnson Syndrome (SJS))</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; blistering of the skin, severe skin reaction (Toxic Epidermal Necrosis (TEN))</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; skin rash accompanied by other symptoms such as fever, swollen glands and an increase of eosinophils (a type of white blood cell). A rash appears as small, itchy red bumps (Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS))</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; skin eruption that is characterised by the rapid appearance of areas of red skin studded with small pustules (small blisters filled with white/yellow fluid) (Acute Generalized Exanthematous Pustulosis (AGEP)).</p><p>&nbsp;</p><p>Stop taking azithromycin if you develop these skin symptoms and contact your doctor or seek medical attention immediately.</p><p>&nbsp;</p><p>The most common side effects that occur when taking Zithromax are listed below. These may go away during treatment as your body adjusts to the medicine. Tell your doctor if any of these side effects continue to bother you:</p><p><strong>&nbsp;</strong></p><p><strong>Very common: may affect more than 1 in 10 people</strong></p><p>&bull; stomach cramps, feeling sick, diarrhoea, wind.</p><p>&nbsp;</p><p><strong>Common: may affect up to 1 in 10 people</strong></p><p>&bull; dizziness, headache</p><p>&bull; numbness or pins and needles</p><p>&bull; being sick, indigestion</p><p>&bull; loss of appetite, taste disturbance</p><p>&bull; visual disturbances, deafness</p><p>&bull; skin rash and /or itching</p><p>&bull; joint pain</p><p>&bull; low numbers of lymphocytes (a type of white blood cell), higher number of eosinophils (type of white blood cells)</p><p>&bull; low blood bicarbonate</p><p>&bull; tiredness or weakness.</p><p>&nbsp;</p><p><strong>Uncommon: may affect up to 1 in 100 people </strong></p><p>&bull; yeast infections of the mouth and vagina (thrush)</p><p>&bull; low numbers of leukocytes (a type of white blood cell), low number of neutrophils (a type of white blood cell)</p><p>&bull; allergic reactions of various severity</p><p>&bull; skin more sensitive to sunlight than normal</p><p>&bull; feeling nervous</p><p>&bull; reduced sense of touch or sensation (hypoesthesia)</p><p>&bull; sleepiness or sleeplessness (insomnia)</p><p>&bull; poor hearing or ringing in the ears</p><p>&bull; heart palpitations, chest pain</p><p>&bull; constipation, stomach pain associated with diarrhoea and fever</p><p>&bull; inflammation of the liver (hepatitis), changes in liver enzymes.</p><p>&bull; general loss of strength</p><p>&bull; swelling</p><p>&bull; general discomfort</p><p>&bull; abnormal laboratory test values (e.g. blood or liver tests).</p><p>&nbsp;</p><p><strong>Rare: may affect up to 1 in 1,000 people</strong></p><p>&bull; agitation</p><p>&bull; vertigo</p><p>&bull; changes in liver function</p><p>&nbsp;</p><p><strong>Not known: frequency cannot be estimated from the available data</strong></p><p>&bull; fits or fainting</p><p>&bull; aggression or anxiety</p><p>&bull; feeling hyperactive</p><p>&bull; localised muscle weakness</p><p>&bull; loss of smell or altered sense of smell, loss of taste</p><p>&bull; tongue discolouration</p><p>&bull; inflammation of the pancreas (pancreatitis)</p><p>&bull; inflammation of the kidney or kidney failure</p><p>&bull; yellowing of the skin or eyes (jaundice) or liver failure (rarely life-threatening)</p><p>&bull; bruising or prolonged bleeding after injury</p><p>&bull; abnormal electrocardiogram (ECG)</p><p>&bull; reduction in red blood cells which can make the skin pale and cause weakness or breathlessness.</p><p><strong>&nbsp;</strong></p><p><strong>Reporting of side effects</strong></p><p>If you get any&nbsp;side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system. By reporting side effects you can help provide more information on the safety of this medicine.</p><p><strong>&nbsp;</strong></p><p><strong>To Report side effects </strong></p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Saudi Arabia</strong></p><p><strong>&nbsp;</strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>National Pharmacovigilance Centre (NPC)</strong></p><ul><li>Call center: 19999</li><li>E-mail: npc.drug@sfda.gov.sa</li><li>Website: https://ade.sfda.gov.sa/&nbsp;&nbsp;</li></ul></td></tr></tbody></table><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Other</strong><strong> GCC States</strong></p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>-&nbsp;&nbsp; <em>Please contact the relevant competent authority.</em></p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is azithromycin (200 mg in 5 ml).</p><p>Other ingredients are sucrose, (see section 2,<strong> </strong>Zithromax contains sucrose) hydroxypropylcellulose, sodium phosphate tribasic anhydrous, xanthan gum and flavourings: artificial banana, artificial cherry and artificial creme de vanilla.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                	Zithromax Suspension is a dry powder which reconstitutes with water to give a cherry/banana flavoured suspension with a slight vanilla odour and comes in the following sizes: 15 ml (600 mg), 22.5 ml (900 mg), and 30 ml (1200 mg) bottles.
	

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>MARKETING AUTHORISATION HOLDER</p><p>Pfizer Saudi Limited &ndash; Saudi Arabia</p><p>&nbsp;</p><p>MANUFACTURER</p><p>Pfizer Saudi Limited, Saudi Arabia</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                July 2023
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">يحتوي هذا الدواء على أزيثروميسن، والذي ينتمي لمجموعة من المضادات الحيوية تُدعى الماكروليدات. وهو يستخدم لعلاج العدوى التي تسببها بعض أنواع البكتيريا وغيرها من الميكروبات الدقيقة، والتي تتضمن:</p><p dir="RTL">&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; عدوى الصدر أو الحلق أو الأنف (مثل الالتهاب الشعبي والالتهاب الرئوي</p><p dir="RTL">&nbsp;والتهاب اللوزتين والتهاب الحلق (التهاب البلعوم) والتهاب الجيوب الأنفية)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; عدوى الأذن</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; عدوى الجلد والنسيج الرخو (مثل الخراج أو الدمّل)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; الأمراض المنقولة جنسيًا التي تسببها كائنات حية تُدعى المتدثرة الحثرية &quot;كلاميديا تراكوماتيس<em>&quot;</em> أو النيسرية البنية &quot;نيسيريا جونوريا&quot;.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يجب أن تتحدث إلى طبيب إذا لم تشعر بتحسن أو إذا ساءت حالتك.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>موانع استعمال زيثروماكس</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت أنت/طفلك مُصابًا بالحساسية تجاه زيثروماكس أو أي من المضادات الحيوية الماكروليدية الأخرى مثل</p><p dir="RTL">إريثروميسين أو كلاريثروميسين أو أي من المكونات الأخرى المذكورة في قسم ٦. قد يتسبب تفاعل الحساسية في حدوث طفح جلدي أو أزيز في الصدر.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الاحتياطات عند استعمال زيثروماكس</strong></p><p dir="RTL">تحدث إلى طبيبك أو الصيدلي قبل تناول زيثروماكس إذا كنت أنت/طفلك تعانيان أو عانيتما من قبل من أي من الحالات التالية:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; مشكلات في الكلى</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; أمراض القلب</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; داء السكري</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; مشكلات في الكبد: قد يحتاج طبيبك لمراقبة وظائف كبدك أو قد يضطر إلى إيقاف العلاج</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; الوهن العضلي الوبيل (حالة تسبب ضعفًا في عضلات معينة)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; أو وإذا كنت تتناول أيًا من مشتقات الإرجوت مثل إرجوتامين (يُستخدم لعلاج الصداع النصفي) حيث ينبغي عدم تناول هذه الأدوية بالتزامن مع زيثروماكس.</p><p dir="RTL">&nbsp;</p><p dir="RTL">أخبر طبيبك على الفور إذا شعرت أن قلبك ينبض بقوة زائدة أو شعرت باضطراب ضربات قلبك أو بالدوار أو الضعف أو عانيت من أي وهن في العضلات أثناء تناول زيثروماكس.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا أصبت بالإسهال أو بليونة البراز أثناء أو بعد العلاج، فأخبر طبيبك على الفور. لا تتناول أي أدوية لعلاج الإسهال قبل الرجوع لطبيبك أولًا. إذا استمر الإسهال، يُرجى إبلاغ طبيبك.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>التداخلات الدوائية من أخذ هذا المستحضر مع أي أدوية أخرى أو أعشاب أو مكملات غذائية</strong></p><p dir="RTL">أخبر طبيبك أو الصيدلي إذا كنت أنت/طفلك تتناولان أو تناولتما مؤخرًا أو قد تتناولان أي أدوية أخرى</p><p dir="RTL">&nbsp;</p><p dir="RTL">على وجه الخصوص، قد يتفاعل زيثروماكس مع الأدوية المدرجة أدناه:</p><p dir="RTL">&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; الإرجوت أو الإرجوتامين، انظر قسم &quot;تحذيرات واحتياطات&quot;.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; وارفاراين وما شابهه من الأدوية المستخدمة للوقاية من جلطات الدم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; سيكلوسبورين (يستخدم لكبت الجهاز المناعي للوقاية من وعلاج حالات رفض الأعضاء المزروعة أو نخاع العظام المزروع)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; مضادات الحموضة (لعلاج عسر الهضم)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; ديجوكسين (يستخدم لعلاج فشل القلب)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; كولشيسين (يستخدم لعلاج النقرس وحمى البحر الأبيض المتوسط العائلية)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; تيرفينادين (لعلاج حمى القش أو حساسية الجلد)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; هيدروكسي كلوروكين أو كلوروكين (المستخدمان في علاج أمراض المناعة الذاتية التي تتضمن التهاب المفاصل الروماتويدي أو لعلاج أو منع الملاريا): أخذ هذه الأدوية في نفس الوقت مع أزثرومايسين قد يزيد من فرصة إصابتك بأعراض جانبية تؤثر على قلبك.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>تناول زيثروماكس مع الطعام والشراب</strong></p><p dir="RTL">يرجى الرجوع إلى القسم ٣.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الحمل والرضاعة</strong></p><p dir="RTL">إذا كنتِ حاملًا أو ترضعين رضاعة طبيعية أو تعتقدين أنك ربما تكونين حاملًا أو تخططين للحمل، فاستشيري طبيبكِ أو الصيدلي قبل تناول هذا الدواء.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>تأثير زيثروماكس على القيادة واستخدام الآلات</strong></p><p dir="RTL">من غير المتوقع أن يؤثر زيثروماكس على قدرتك على القيادة أو استخدام الآلات.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>يحتوي معلق </strong><strong>زيثروماكس </strong><strong>على السكروز</strong><strong>، </strong>وهو نوع من السكريات. إذا أخبرك طبيبك أنك لا تستطيع تحمل بعض السكريات، فاتصل به قبل تناول هذا الدواء. إذا كنت مريضًا بالسكري، فقد تحتاج إلى وضع هذه المعلومة في عين الاعتبار فيما يخص نظامك الغذائي.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>معلومات عن محتوى الدواء من الصوديوم</strong></p><p dir="RTL">يحتوي زيثروماكس على أقل من ١ ملي مول من الصوديوم (٢٣ ملجم) لكل ٥ مل من المعلق المحضر، لذا يُعد &quot;خاليًا من الصوديوم&quot; تقريبًا.</p><p dir="RTL"><strong>&nbsp;</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">احرص دومًا على تناول أو إعطاء هذا الدواء تمامًا كما أخبرك طبيبك. استشر طبيبك أو الصيدلي إذا لم تكن متأكدًا مما يجب عليك فعله.</p><p dir="RTL">&nbsp;</p><p dir="RTL">من المفترض أن يكون الصيدلي قد أخبرك إذا ما كان عليك قياس جرعة الدواء باستخدام الملعقة متعددة الجرعات أو محقنة معايرة الجرعات للاستعمال عبر الفم (عبوة 15 مل فقط).</p><p dir="RTL">&nbsp;</p><p dir="RTL">يستخدم شراب زيثروماكس المُعلق بشكل عام مع الأطفال الذي يقل وزنهم عن ٧ ستون (٤٥ كجم). كما يُمكن استخدامه مع البالغين والأطفال الأكبر سنًا الذين يواجهون صعوبة في بلع الكبسولات.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا يتأثر معلق زيثروماكس بالطعام أو الشراب.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الأطفال الذين يقل وزنهم عن ٤٥ كجم</strong></p><p dir="RTL">الجرعة الموصى بها للأطفال هي ١٠ ملجم لكل كجم من وزن الجسم، يتم إعطاؤها كجرعة فردية يومية لمدة ٣ أيام.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>البالغون والأطفال الذين يزيد وزنهم عن ٤٥ كجم</strong></p><p dir="RTL">الجرعة الموصى بها للبالغين والأطفال الذين يزيد وزنهم عن ٧ ستون (٤٥ كجم) هي ٥٠٠ ملجم يتم تناولها في صورة جرعة فردية لمدة ٣ أيام. بالنسبة لبعض الأمراض مثل داء الكلاميديا، تكون الجرعة الموصى بها هي ١ جم يوميًا ويتم تناولها في صورة جرعة فردية. بالنسبة لداء السيلان، تكون الجرعة الموصى بها هي ١ جم أو ٢ جم من أزثرومايسين مع ٢٥٠ أو ٥٠٠ ملجم من سيفترياكسون.</p><p dir="RTL">&nbsp;</p><p dir="RTL">ينبغي عليك إبلاغ طبيبك إذا كنت تعاني أنت/طفلك من مشكلات في الكلى أو الكبد، حيث قد يضطر الطبيب إلى تعديل الجرعة المعتادة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يصف الأطباء في بعض الأحيان جرعات مختلفة عن الجرعة الموصى بها. سيخبرك الملصق الموجود على العبوة أي جرعة ينبغي أن تأخذها أنت/طفلك. إذا كنت لا تزال غير متأكد، فاسأل طبيبك أو الصيدلي.</p><p dir="RTL">&nbsp;</p><p dir="RTL">احرص دومًا على استكمال دورة العلاج حتى وإن شعرت أنت/طفلك بتحسن. إذا ما تفاقمت العدوى أو إذا لم تبدأ في الشعور بالتحسن خلال بضعة أيام أو إذا أصبت بعدوى جديدة، فقم بزيارة طبيبك مرة أخرى.</p><p dir="RTL"><u>&nbsp;</u></p><p dir="RTL"><strong>كيفية إعطاء شراب زيثروماكس المعلق للأطفال أقل من ٣ أعوام</strong></p><p dir="RTL">إذا كان عمر طفلك أقل من ٣ أعوام أو كان وزن جسمه يصل إلى ١٥ كجم، ينبغي عليك قياس الجرعة بأكبر قدر ممكن من الدقة باستخدام محقنة معايرة الجرعات الخاصة بالاستعمال عن طريق الفم سعة ١٠ مل المرفقة مع الدواء. ستجد المحقنة مُدرّجة في صورة درجات قدر كل منها ٠,٢٥ مل، لتعطي ١٠ ملجم من أزثرومايسين (المادة الفعالة) لكل تدريج.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>أ.</strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>تعليمات استخدام المحقنة</strong></p><p dir="RTL"><u>&nbsp;</u></p><p><strong>ملء المحقنة بالدواء</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">١.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قم برج الزجاجة قبل استخدامها وأزل الغطاء الآمن من عبث الأطفال.</p><p dir="RTL">&nbsp;</p><p dir="RTL">٢.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ينبغي أن يكون الصيدلي قد قام بتثبيت مهايئ للمحقنة على عنق زجاجة الدواء. إذا لم يقم الصيدلي بذلك، فانزع المهايئ من المحقنة وثبته في عنق الزجاجة كما هو موضح. الغرض من مهايئ المحقنة هو أن يمكِّنك من ملء المحقنة بالدواء من الزجاجة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">٣.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تحقق من ملصق توضيح الجرعة الذي وضعه الصيدلي لمعرفة المقدار الذي ينبغي تناوله من الدواء.</p><p dir="RTL">&nbsp;</p><p dir="RTL">٤.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أمسك الزجاجة بثبات بيد واحدة مع وضعها على سطح صلب ومُسطّح. باليد الأخرى، أدخل طرف المحقنة في قطعة الربط.</p><p dir="RTL">&nbsp;</p><p dir="RTL">٥.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اقلب الزجاجة مع تثبيت المحقنة في مكانها.</p><p dir="RTL">&nbsp;</p><p dir="RTL">٦.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اسحب مكبس المحقنة ببطء حتى يصبح طرفه العلوي عند مستوى علامة التدريج المقابل لكمية الدواء التي وصفها طبيبك بالمليلتر (مل).</p><p dir="RTL">&nbsp;</p><p dir="RTL">٧.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت ترى فقاعات كبيرة في المحقنة، فاضغط على المكبس ببطء إلى داخل المحقنة مرة أخرى. سيُخرج ذلك الدواء مجددًا إلى الزجاجة. ثم كرر الخطوة رقم ٦ مرة أخرى.</p><p dir="RTL">&nbsp;</p><p dir="RTL">٨.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أمسك المحقنة والزجاجة بثبات. اقلب الزجاجة مرة أخرى، مع تثبيت المحقنة في مكانها.</p><p dir="RTL">&nbsp;</p><p dir="RTL">٩.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أخرج المحقنة من الزجاجة.</p><p dir="RTL">&nbsp;</p><p><strong>إعطاء الدواء باستخدام المحقنة</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">١.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تأكد من وضع طفلك في وضع قائم مع دعم جسمه.</p><p dir="RTL">&nbsp;</p><p dir="RTL">٢.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضع طرف المحقنة بحرص في فم طفلك. وجّه طرف المحقنة نحو الجهة الداخلية من خد الطفل.</p><p dir="RTL">&nbsp;</p><p dir="RTL">٣.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضغط على مكبس المحقنة ببطء: <strong>لا تضغط عليه بسرعة.</strong> سيسيل الدواء ببطء في فم الطفل.</p><p dir="RTL">&nbsp;</p><p dir="RTL">٤.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أمهل طفلك بعض الوقت ليتمكن من بلع الدواء.</p><p dir="RTL">&nbsp;</p><p dir="RTL">٥.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أعد الغطاء الآمن من عبث الأطفال على الزجاجة. اغسل المحقنة وفقًا للتعليمات الواردة أدناه.</p><p dir="RTL">&nbsp;</p><p dir="RTL">٦.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا تم إعطاء جرعات يومية تقل عن ٥ مل لمدة ثلاثة أيام، ستبقى كمية قليلة من المعلق في الزجاجة. ينبغي التخلص من هذه الكمية المتبقية من المعلق.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>تنظيف وتخزين المحقنة</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">١.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اسحب المكبس من المحقنة واغسل كليهما بوضعهما تحت الماء الجاري</p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الدافئ أو بغمرهما في المحلول المعقم المستخدم في تعقيم زجاجات</p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إرضاع الأطفال، إلخ.</p><p dir="RTL">&nbsp;</p><p dir="RTL">٢.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قم بتجفيف القطعتين. أدخل المكبس مجددًا إلى المحقنة. احتفظ بها مع الدواء في مكان نظيف وآمن. بعد إعطاء طفلك الجرعة الأخيرة من الدواء، ضع المحقنة في قطعة من أوراق الجرائد، وتخلص منها في سلة المهملات.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>كيفية إعطاء شراب زيثروماكس المعلق للأطفال ما بين ٣ أعوام و١٤ عامًا من العمر</strong></p><p dir="RTL"><u>&nbsp;</u></p><table dir="rtl" border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p dir="RTL"><strong>وزن الجسم والعمر</strong></p></td><td style="vertical-align:top"><p dir="RTL"><strong>الجرعة ومدة الاستخدام</strong></p><p dir="RTL"><u>&nbsp;</u></p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">وزن جسم يتراوح ما بين ١٥-٢٥ كجم (٣-٧ أعوام):</p><p dir="RTL">(يتراوح بين ٢,٥ و٤ ستون)</p></td><td style="vertical-align:top"><p dir="RTL">٥ مل (٢٠٠ ملجم)، ملء ملعقة واحدة بحجم ٥ مل، مرة واحدة يوميًا لمدة ٣ أيام.</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">وزن جسم يتراوح ما بين ٢٦-٣٥ كجم (٨-١١ عامًا): (يتراوح بين ٤ و٥,٥ ستون)</p></td><td style="vertical-align:top"><p dir="RTL">٧,٥ مل (٣٠٠ ملجم)، ملء ملعقة واحدة بحجم ٧,٥ مل، مرة واحدة يوميًا لمدة ٣ أيام.</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">وزن جسم يتراوح ما بين ٣٦-٤٥ كجم (١٢-١٤ عامًا): (يتراوح بين ٥,٥ و٧ ستون)</p></td><td style="vertical-align:top"><p dir="RTL">١٠ مل (٤٠٠ ملجم)، ملء ملعقة واحدة بحجم ١٠ مل، مرة واحدة يوميًا لمدة ٣ أيام.</p></td></tr></tbody></table><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>ب.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تعليمات استخدام الملعقة البلاستيكية</strong></p><p dir="RTL">ينبغي عدم استخدام الملعقة مع الأطفال الذين تقل أعمارهم عن ٣ أعوام (أقل من ٢,٥ ستون).</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إعطاء الدواء باستخدام الملعقة.</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">١.&nbsp; تُرفق مع الدواء ملعقة بلاستيكية ذات طرفين. تحقق من طرف الملعقة والمستوى المناسبين للحصول على الجرعة المطلوبة. إذا كنت غير متأكد مما عليك فعله، فتحقق من طبيبك أو الصيدلي. تستخدم هذه الملعقة متعددة الجرعات لإعطاء الجرعات كما يلي:</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">٢,٥ مل&nbsp; (١٠٠ ملجم)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الطرف الصغير &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;إلى التدريج المناسب</p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (رسم توضيحي)</p><p dir="RTL">٥ مل&nbsp; (٢٠٠ ملجم)&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الطرف الصغير &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;إلى الحافة</p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (رسم توضيحي)</p><p dir="RTL">٧,٥ مل&nbsp;&nbsp; (٣٠٠ ملجم)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الطرف الكبير&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;إلى التدريج المناسب</p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (رسم توضيحي)</p><p dir="RTL">١٠ مل (٤٠٠ ملجم)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الطرف الكبير&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إلى الحافة</p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (رسم توضيحي)</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">٢.&nbsp;&nbsp; قم برج الزجاجة جيدًا ثم أزل الغطاء الآمن من عبث الأطفال.</p><p dir="RTL">٣.&nbsp;&nbsp; قم بصب الدواء برفق في الملعقة بالمقدار اللازم لإعطاء الجرعة الصحيحة.</p><p dir="RTL">٤.&nbsp;&nbsp; أمهل المريض بعض الوقت لبلع الدواء ببطء.</p><p dir="RTL">٥.&nbsp;&nbsp; اغسل الملعقة تحت ماء جارٍ دافئ. جففها وخزنها مع الدواء في مكان آمن.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>تحذير: إذا كنت ستعطي هذا الدواء لطفل، فاحرص على وضعه مستندًا في وضع قائم أثناء تلقيه الدواء لتجنب خطر الاختناق.</strong></p><p>&nbsp;</p><p><strong>الجرعة الزائدة من زيثروماكس</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا تناولت أنت/طفلك أكثر مما ينبغي من زيثروماكس، فقد تشعر بالتوعك. إذا حدث ذلك أخبر طبيبك على الفور أو اتصل بقسم الحوادث في أقرب مستشفى. أحضر معك ما تبقى من الدواء.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>نسيان تناول جرعة زيثروماكس</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا نسيت تناول جرعة زيثروماكس، تناولها في أسرع وقت ممكن. ثم تناول الجرعة التالية في الوقت المعتاد المحدد لها. لا تتناول جرعة مزدوجة لتعويض الجرعة التي نسيتها.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>التوقف عن تناول زيثروماكس</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا توقفت أنت أو طفلك عن تناول زيثروماكس في وقت مبكر، قد تصابان بالعدوى مجددًا. يتم تناول زيثروماكس للمدة الكاملة للعلاج حتى إذا بدأت أنت أو طفلك الشعور بتحسن.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا كان لديك مزيد من الأسئلة حول استخدام هذا الدواء، فاسأل طبيبك أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثل جميع الأدوية، يمكن أن يتسبب هذا الدواء في حدوث أعراض جانبية إلا أنها قد لا تصيب الجميع.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>أخبر طبيبك على الفور إذا أصبت بأي من الأعراض التالية بعد تناول هذا الدواء، حيث قد تكون هذه الأعراض حادة. </strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;الحالات المفاجئة من الأزيز أو صعوبة التنفس أو تورم الجفون أو الوجه أو الشفتين أو الطفح الجلدي&nbsp;</p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أو الحكة (خاصة التي تؤثر على الجسم بأكمله)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إسهال شديد أو مُطوَّل، الذي قد يحتوي على دم أو مخاط، أثناء أو&nbsp;</p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;بعد العلاج بزيثروماكس، حيث قد يكون ذلك علامة إلى وجود التهاب خطير</p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;في الأمعاء</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي حاد يسبب احمرار الجلد وتقشره</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تسارع أو عدم انتظام ضربات القلب</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض ضغط الدم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;تفاعلات جلدية خطيرة:</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تقرح الجلد، والفم، والعينين، والأعضاء التناسلية (متلازمة ستيفنز-جونسون ((SJS)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تقرح الجلد، تفاعل جلدي شديد (تقشر الأنسجة المتموتة البشروية التسممي ((TEN)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي تصاحبه أعراض أخرى مثل الحمى، وتورم الغدد، وزيادة في اليوزينيات (نوع من خلايا الدم البيضاء). يظهر الطفح الجلدي في شكل نتوءات صغيرة حمراء مثيرة للحكة (تفاعل دوائي مصحوب بكثرة اليوزينيات وأعراض جهازية (DRESS)).</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي يتسم بظهور سريع لمناطق حمراء في الجلد مغطاة ببثور متقيحة صغيرة (بثور صغيرة مليئة بسائل أبيض/أصفر)) بثار طفحي معمم حاد (AGEP).(</p><p dir="RTL">توقف عن استخدام أزثرومايسين إذا أصبت بهذه الأعراض الجلدية وتواصل مع طبيبك واطلب الحصول على الرعاية الطبية فورًا.</p><p dir="RTL">&nbsp;</p><p dir="RTL">الآثار الجانبية الأكثر شيوعًا والتي قد تحدث عند تناول زيثروماكس، مدرجة أدناه. قد تختفي هذه الآثار أثناء العلاج بينما يتكيف جسمك مع الدواء. أخبر طبيبك إذا ما استمرت معاناتك من أي من هذه الآثار الجانبية:</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>شائعة جدًا: قد تصيب أكثر من شخص واحد بين كل ١٠ أشخاص</strong></p><p dir="RTL">&bull; تقلصات المعدة، الشعور بالغثيان، الإسهال، غازات البطن.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>شائعة: قد تصيب ما يصل إلى شخص واحد بين كل ١٠ أشخاص</strong></p><p dir="RTL">&bull; الدوخة، الصداع</p><p dir="RTL">&bull; الخدر أو الشكشكة والوخز</p><p dir="RTL">&bull; الشعور بالغثيان، عسر الهضم</p><p dir="RTL">&bull; فقدان الشهية، اضطراب حاسة التذوق</p><p dir="RTL">&bull; اضطرابات الرؤية، الصمم</p><p dir="RTL">&bull; الطفح الجلدي و/أو الحكة</p><p dir="RTL">&bull; ألم المفاصل</p><p dir="RTL">&bull; انخفاض تعداد الليمفاويات (نوع من خلايا الدم البيضاء)، ارتفاع تعداد اليوزينيات (نوع من خلايا الدم البيضاء)</p><p dir="RTL">&bull; انخفاض مستوى البيكربونات في الدم</p><p dir="RTL">&bull; التعب أو الضعف.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>غير شائعة: قد تصيب ما يصل إلى شخص واحد من بين كل ١٠٠ شخص </strong></p><p dir="RTL">&bull; عدوى فطرية في الفم والمهبل (القلاع)</p><p dir="RTL">&bull; انخفاض تعداد الكريات البيضاء (نوع من خلايا الدم البيضاء)، انخفاض تعداد العدلات (نوع من خلايا الدم البيضاء)</p><p dir="RTL">&bull; تفاعلات حساسية متفاوتة الشدة</p><p dir="RTL">&bull; زيادة حساسية الجلد لضوء الشمس عن المستوى الطبيعي</p><p dir="RTL">&bull; الشعور بالتوتر</p><p dir="RTL">&bull; ضعف حاسة اللمس أو القدرة على الإحساس باللمس (نقص الإحساس)</p><p dir="RTL">&bull; النعاس أو قلة النوم (الأرق)</p><p dir="RTL">&bull; ضعف السمع أو طنين الأذن</p><p dir="RTL">&bull; خفقان القلب، ألم الصدر</p><p dir="RTL">&bull; الإمساك، ألم المعدة المصحوب بالإسهال والحمى</p><p dir="RTL">&bull; التهاب الكبد، تغيرات في مستويات إنزيمات الكبد</p><p dir="RTL">&bull; فقدان عام في القوة البدنية</p><p dir="RTL">&bull; التورم</p><p dir="RTL">&bull; شعور عام بالضيق</p><p dir="RTL">&bull; نتائج غير طبيعية في الفحوصات المعملية (مثل فحوصات الدم أو الكبد.(</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>نادرة: قد تصيب ما يصل إلى شخص واحد بين كل ١٠٠٠ شخص</strong></p><p dir="RTL">&bull; التهيج</p><p dir="RTL">&bull; الدوخة</p><p dir="RTL">&bull; تغيرات في وظائف الكبد</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>غير معروفة: لا يمكن تحديد معدل تكرار حدوثها من البيانات المتاحة</strong></p><p dir="RTL">&bull; نوبات أو إغماء</p><p dir="RTL">&bull; العدوانية أو القلق</p><p dir="RTL">&bull; الشعور بفرط النشاط</p><p dir="RTL">&bull; ألم موضعي في العضلات</p><p dir="RTL">&bull; فقدان القدرة على الشم أو تغير حاسة الشم، فقدان التذوق</p><p dir="RTL">&bull; تغير لون اللسان</p><p dir="RTL">&bull; التهاب البنكرياس</p><p dir="RTL">&bull; التهاب الكلى أو الفشل الكلوي</p><p dir="RTL">&bull; اصفرار لون البشرة أو العينين (اليرقان) أو فشل الكبد (نادرًا ما تكون مهددة للحياة)</p><p dir="RTL">&bull; التكدُّم أو النزيف المستمر بعد التعرض للإصابة</p><p dir="RTL">&bull; نتائج غير طبيعية برسم القلب (ECG)</p><p dir="RTL">&bull; انخفاض خلايا الدم الحمراء، الأمر الذي قد يجعل لون الجلد شاحبًا ويسبب الضعف أو ضيق التنفس.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الإبلاغ عن الأعراض الجانبية</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">إذا تعرضت للإصابة بأي عرض جانبي، فتحدث إلى طبيبك أو الصيدلي. يشتمل هذا على أي آثار جانبية محتملة وغير مدرجة في هذه النشرة. يمكنك أيضًا الإبلاغ عن الآثار الجانبية مباشرةً عبر نظام الإبلاغ القومي. بإبلاغك عن الآثار الجانبية، يمكنك المساعدة في توفير المزيد من المعلومات حول سلامة هذا الدواء.</p><p dir="RTL">&nbsp;</p><p><strong>ل</strong><strong>لإبلاغ عن الأعراض الجانبية</strong></p><p><strong>&nbsp;</strong></p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>المملكة العربية السعودية</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p dir="RTL"><strong>المركز الوطني للتيقظ الدوائي</strong><strong> </strong></p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الهاتف المجاني: ١٩٩٩٩</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البريد الإلكتروني: npc.drug@sdfa.gov.sa</p><p dir="RTL"><em>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>الموقع الإلكتروني: https://ade.sfda.gov.sa/</p></td></tr></tbody></table><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>دول الخليج الأخرى</strong></p><p dir="RTL">&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p dir="RTL"><em>-&nbsp;&nbsp; </em><em>الرجاء الاتصال بالمؤسسات والهيئات الوطنية في كل دولة.</em></p></td></tr></tbody></table>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يحفظ في درجة حرارة أقل من ٣٠ درجة مئوية.</p><p dir="RTL">بعد حل المسحوق بالماء، فإن المحلول المعلق الذي يعطى من خلال الفم يبقى صالحاً للإستخدام مدة ٥ أيام في درجة حرارة أقل من ۳٠ درجة مئوية.</p><p dir="RTL">احتفظ بهذا الدواء بعيدًا عن مرأى ومتناول الأطفال.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا <strong>تتناول</strong> <strong>أو</strong> <strong>تقم بإعطاء </strong>هذا الدواء بعد انتهاء فترة الصلاحية المُبينة على الزجاجة بعد رمز انتهاء الصلاحية &quot;EXP&quot;. يشير تاريخ انتهاء الصلاحية إلى أخر يوم من الشهر المذكور.</p><p dir="RTL">&nbsp;</p><p dir="RTL">ينبغي التخلص من الكميات المتبقية من الدواء بعد ٥ أيام.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا تتخلص من أي أدوية عبر مياه الصرف أو في المخلفات المنزلية. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد تستخدمها. ستساعد هذه التدابير على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">المادة الفعالة هي أزثرومايسين (٢٠٠ ملجم في ٥ مل).</p><p dir="RTL">المكونات الأخرى هي السكروز (انظر القسم ٢، يحتوي معلق زيثروماكس على السكروز)، هيدروكسي بروبيل سليولوز، فوسفات صوديوم لا مائي ثلاثي القاعدية، صمغ زانثان ومكسبات طعم: طعم الموز الصناعي، وطعم الكرز الصناعي وطعم كريمة الفانيليا الصناعي.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:right">معلّق زيثروماكس عبارة عن مسحوق جاف يُحضَّر مع الماء لإعطاء مُعلّق بنكهة الكرز/الموز مع رائحة فانيليا خفيفة ويأتي في الأحجام التالية: زجاجات سعة ١٥ مل (٦٠٠ ملجم)، و ٥, ٢٢مل (٩٠٠ ملجم)، و٣٠ مل (١٢٠٠ ملجم).</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>مالك حق التسويق</p><p>Pfizer Saudi Limited &ndash; Saudi Arabia</p><p>&nbsp;</p><p>الشركة المصنعة</p><p>Pfizer Saudi Limited, Saudi Arabia</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            يوليو/تموز ٢٠٢٣
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Zithromax 200 mg in 5 ml suspension
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Zithromax Powder for Oral Suspension is a dry blend of azithromycin dihydrate 209.64 mg per 5 ml, containing the equivalent of 200 mg azithromycin base, on reconstitution with water. 

Excipients with known effect:
Also contains Sucrose.

For the full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Powder for Oral Suspension
A dry powder which reconstitutes with water to give a cherry/banana flavoured suspension with a slight vanilla odour.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Azithromycin is indicated for the treatment of the following infections when known or likely to be due to one or more susceptible microorganisms (see section 5.1):</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - bronchitis</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - community-acquired pneumonia</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - sinusitis</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - pharyngitis/tonsillitis (see section 4.4 regarding streptococcal infections)</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - otitis media</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - skin and soft tissue infections</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - uncomplicated genital infections due to <em>Chlamydia trachomatis and </em><em>Neisseria gonorrhoeae.</em></p><p>&nbsp;</p><p>Considerations should be given to official guidance regarding the appropriate use of antibacterial agents.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Posology</u></p><p>Zithromax should be given as a single daily dose.</p><p>&nbsp;</p><p>Zithromax Suspension can be taken with or without food.</p><p>&nbsp;</p><p><strong>Children over 45 kg body weight and</strong> <strong>adults, including elderly patients:</strong> The total dose of azithromycin is 1500 mg which should be given over three days (500 mg once daily).</p><p>&nbsp;</p><p>In uncomplicated genital infections due to <em>Chlamydia trachomatis</em>, the dose is 1000 mg as a single oral dose. For susceptible <em>Neisseria gonorrhoeae</em> the recommended dose is 1000&nbsp;mg or 2000&nbsp;mg of azithromycin in combination with 250 mg or 500&nbsp;mg ceftriaxone according to local clinical treatment guidelines. For patients who are allergic to penicillin and/or cephalosporins, prescribers should consult local treatment guidelines.</p><p>&nbsp;</p><p><strong>Paediatric population:</strong></p><p><strong>In children under 45 kg body weight</strong>: Zithromax Suspension should be used for children under 45 kg. There is no information on children less than 6 months of age. The dose in children is 10 mg/kg as a single daily dose for 3 days:</p><p>&nbsp;</p><p><em>Up to 15 kg (less than 3 years):</em> Measure the dose as closely as possible using the 10 ml oral dosing syringe provided. The syringe is graduated in 0.25 ml divisions, providing 10 mg of azithromycin in every graduation.</p><p>&nbsp;</p><p><em>For children weighing more than 15 kg</em>, Zithromax Suspension should be administered using the spoon provided according to the following guidance:</p><p>&nbsp;</p><p>15-25 kg (3-7 years): 5 ml (200 mg) given as 1 x 5 ml spoonful, once daily for 3 days.</p><p>&nbsp;</p><p>26-35 kg (8-11 years): 7.5 ml (300 mg) given as 1 x 7.5 ml spoonful, once daily for 3 days.</p><p>&nbsp;</p><p>36-45 kg (12-14 years): 10 ml (400 mg) given as 1 x 10 ml spoonful, once daily for 3 days.</p><p>&nbsp;</p><p><strong>Over 45 kg: Dose as per adults. </strong></p><p>See section 6.5 for appropriate pack size to use depending on age/body weight of child.</p><p>&nbsp;</p><p>The specially supplied measure should be used to administer Zithromax suspension to children.</p><p>&nbsp;</p><p><strong>Renal impairment:</strong></p><p>No dose adjustment is necessary in patients with GFR&nbsp;10&nbsp;&ndash;&nbsp;80&nbsp;ml/min. Caution should be exercised when azithromycin is administered to patients with GFR &lt; 10 ml/min (see section 4.4 and section 5.2).</p><p>&nbsp;</p><p><strong>Hepatic impairment: </strong></p><p>Since azithromycin is metabolised in the liver and excreted in the bile, the drug should not be given to patients suffering from severe liver disease. No studies have been conducted regarding treatment of such patients with azithromycin (see section 4.4).</p><p>&nbsp;</p><p><u>Method of administration</u></p><p>Zithromax Suspension is for oral administration only.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Zithromax is contra-indicated in patients with a known hypersensitivity to azithromycin, erythromycin, any macrolide or ketolide antibiotic, or to any of the excipients (listed in section 6.1). 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Hypersensitivity</u></p><p>As with erythromycin and other macrolides, serious allergic reactions including angioneurotic oedema and anaphylaxis (rarely fatal), Acute Generalized Exanthematous Pustulosis (AGEP) and Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) have been reported. Some of these reactions with azithromycin have resulted in recurrent symptoms and required a longer period of observation and treatment.</p><p>&nbsp;</p><p><u>Hepatotoxicity</u></p><p>Since the liver is the principal route of elimination for azithromycin, the use of azithromycin should be undertaken with caution in patients with significant hepatic disease. Cases of fulminant hepatitis potentially leading to life-threatening liver failure have been reported with azithromycin (see section 4.8). Some patients may have had pre-existing hepatic disease or may have been taking other hepatotoxic medicinal products.</p><p>&nbsp;</p><p>In case of signs and symptoms of liver dysfunction, such as rapid developing asthenia associated with jaundice, dark urine, bleeding tendency or hepatic encephalopathy, liver function tests / investigations should be performed immediately. Azithromycin administration should be stopped if liver dysfunction has emerged.</p><p>&nbsp;</p><p><u>Ergot derivatives</u></p><p>In patients receiving ergot derivatives, ergotism has been precipitated by co-administration of some macrolide antibiotics. There are no data concerning the possibility of an interaction between ergot and azithromycin. However, because of the theoretical possibility of ergotism, azithromycin and ergot derivatives should not be co-administrated.</p><p>&nbsp;</p><p><u>Prolongation of the QT interval</u></p><p>Prolonged cardiac repolarisation and QT interval, imparting a risk of developing cardiac arrhythmia and torsades de pointes, have been seen in treatment with other macrolides. A similar effect with azithromycin cannot be completely ruled out in patients at increased risk for prolonged cardiac repolarisation (see section 4.8); therefore caution is required when treating patients:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; With congenital or documented QT prolongation</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Currently receiving treatment with other active substance known to prolong QT interval such as antiarrhythmics of Classes Ia and III, cisapride and terfenadine</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; With electrolyte disturbance, particularly in case of hypokalaemia and hypomagnesemia</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; With clinically relevant bradycardia, cardiac arrhythmia or severe cardiac insufficiency.</p><p>&nbsp;</p><p><u>Superinfection</u></p><p>As with any antibiotic preparation, observation for signs of superinfection with non-susceptible organisms including fungi is recommended.</p><p>&nbsp;</p><p><em><u>Clostridium difficile</u></em><u> associated diarrhoea</u></p><p><em>Clostridium difficile</em> associated diarrhoea (CDAD) has been reported with the use of nearly all antibacterial agents, including azithromycin, and may range in severity from mild diarrhoea to fatal colitis. Strains of <em>C. difficile</em> producing hypertoxin A and B contribute to the development of CDAD. Hypertoxin producing strains of <em>C. difficile </em>cause increased morbidity and mortality, as these infections can be refractory to antimicrobial therapy and may require colectomy. Therefore, CDAD must be considered in patients who present with diarrhoea during or subsequent to the administration of any antibiotics. Careful medical history is necessary since CDAD has been reported to occur over 2 months after the administration of antibacterial agents. Discontinuation of therapy with azithromycin and the administration of specific treatment for <em>C. difficile</em> should be considered.</p><p>&nbsp;</p><p><u>Streptococcal infections</u></p><p>Penicillin is usually the first choice for treatment of pharyngitis/tonsillitis due to <em>Streptococcus pyogenes</em> and also for prophylaxis of acute rheumatic fever. Azithromycin is in general effective against streptococcus in the oropharynx, but no data are available that demonstrate the efficacy of azithromycin in preventing acute rheumatic fever.</p><p>&nbsp;</p><p><u>Renal impairment</u></p><p>In patients with GFR &lt;10 ml/min a 33% increase in systemic exposure to azithromycin was observed (see section 5.2).</p><p>&nbsp;</p><p><u>Myasthenia gravis</u></p><p>Exacerbations of the symptoms of myasthenia gravis and new onset of myasthenia syndrome have been reported in patients receiving azithromycin therapy (see section 4.8).</p><p>&nbsp;</p><p><u>Hydroxychloroquine or chloroquine</u></p><p>Carefully consider the balance of benefits and risks before prescribing azithromycin for any patients taking hydroxychloroquine or chloroquine, because of the potential for an increased risk of cardiovascular events and cardiovascular mortality (see section 4.5).</p><p>&nbsp;</p><p><u>Diabetes</u></p><p>Caution in diabetic patients: 5 ml of reconstituted suspension contains sucrose.</p><p>&nbsp;</p><p><u>Excipients information</u></p><p>Zithromax suspension contains sucrose. Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine.</p><p>&nbsp;</p><p>Zithromax suspension contains less than 1 mmol sodium (23 mg) per 5 ml of reconstituted suspension, that is to say essentially &lsquo;sodium-free&rsquo;.</p><p>&nbsp;</p><p>Zithromax Suspension is for oral administration only.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Hypersensitivity</u></p><p>As with erythromycin and other macrolides, serious allergic reactions including angioneurotic oedema and anaphylaxis (rarely fatal), Acute Generalized Exanthematous Pustulosis (AGEP) and Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) have been reported. Some of these reactions with azithromycin have resulted in recurrent symptoms and required a longer period of observation and treatment.</p><p>&nbsp;</p><p><u>Hepatotoxicity</u></p><p>Since the liver is the principal route of elimination for azithromycin, the use of azithromycin should be undertaken with caution in patients with significant hepatic disease. Cases of fulminant hepatitis potentially leading to life-threatening liver failure have been reported with azithromycin (see section 4.8). Some patients may have had pre-existing hepatic disease or may have been taking other hepatotoxic medicinal products.</p><p>&nbsp;</p><p>In case of signs and symptoms of liver dysfunction, such as rapid developing asthenia associated with jaundice, dark urine, bleeding tendency or hepatic encephalopathy, liver function tests / investigations should be performed immediately. Azithromycin administration should be stopped if liver dysfunction has emerged.</p><p>&nbsp;</p><p><u>Ergot derivatives</u></p><p>In patients receiving ergot derivatives, ergotism has been precipitated by co-administration of some macrolide antibiotics. There are no data concerning the possibility of an interaction between ergot and azithromycin. However, because of the theoretical possibility of ergotism, azithromycin and ergot derivatives should not be co-administrated.</p><p>&nbsp;</p><p><u>Prolongation of the QT interval</u></p><p>Prolonged cardiac repolarisation and QT interval, imparting a risk of developing cardiac arrhythmia and torsades de pointes, have been seen in treatment with other macrolides. A similar effect with azithromycin cannot be completely ruled out in patients at increased risk for prolonged cardiac repolarisation (see section 4.8); therefore caution is required when treating patients:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; With congenital or documented QT prolongation</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Currently receiving treatment with other active substance known to prolong QT interval such as antiarrhythmics of Classes Ia and III, cisapride and terfenadine</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; With electrolyte disturbance, particularly in case of hypokalaemia and hypomagnesemia</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; With clinically relevant bradycardia, cardiac arrhythmia or severe cardiac insufficiency.</p><p>&nbsp;</p><p><u>Superinfection</u></p><p>As with any antibiotic preparation, observation for signs of superinfection with non-susceptible organisms including fungi is recommended.</p><p>&nbsp;</p><p><em><u>Clostridium difficile</u></em><u> associated diarrhoea</u></p><p><em>Clostridium difficile</em> associated diarrhoea (CDAD) has been reported with the use of nearly all antibacterial agents, including azithromycin, and may range in severity from mild diarrhoea to fatal colitis. Strains of <em>C. difficile</em> producing hypertoxin A and B contribute to the development of CDAD. Hypertoxin producing strains of <em>C. difficile </em>cause increased morbidity and mortality, as these infections can be refractory to antimicrobial therapy and may require colectomy. Therefore, CDAD must be considered in patients who present with diarrhoea during or subsequent to the administration of any antibiotics. Careful medical history is necessary since CDAD has been reported to occur over 2 months after the administration of antibacterial agents. Discontinuation of therapy with azithromycin and the administration of specific treatment for <em>C. difficile</em> should be considered.</p><p>&nbsp;</p><p><u>Streptococcal infections</u></p><p>Penicillin is usually the first choice for treatment of pharyngitis/tonsillitis due to <em>Streptococcus pyogenes</em> and also for prophylaxis of acute rheumatic fever. Azithromycin is in general effective against streptococcus in the oropharynx, but no data are available that demonstrate the efficacy of azithromycin in preventing acute rheumatic fever.</p><p>&nbsp;</p><p><u>Renal impairment</u></p><p>In patients with GFR &lt;10 ml/min a 33% increase in systemic exposure to azithromycin was observed (see section 5.2).</p><p>&nbsp;</p><p><u>Myasthenia gravis</u></p><p>Exacerbations of the symptoms of myasthenia gravis and new onset of myasthenia syndrome have been reported in patients receiving azithromycin therapy (see section 4.8).</p><p>&nbsp;</p><p><u>Hydroxychloroquine or chloroquine</u></p><p>Carefully consider the balance of benefits and risks before prescribing azithromycin for any patients taking hydroxychloroquine or chloroquine, because of the potential for an increased risk of cardiovascular events and cardiovascular mortality (see section 4.5).</p><p>&nbsp;</p><p><u>Diabetes</u></p><p>Caution in diabetic patients: 5 ml of reconstituted suspension contains sucrose.</p><p>&nbsp;</p><p><u>Excipients information</u></p><p>Zithromax suspension contains sucrose. Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine.</p><p>&nbsp;</p><p>Zithromax suspension contains less than 1 mmol sodium (23 mg) per 5 ml of reconstituted suspension, that is to say essentially &lsquo;sodium-free&rsquo;.</p><p>&nbsp;</p><p>Zithromax Suspension is for oral administration only.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pregnancy</u></p><p>Animal reproduction studies have been performed at doses up to moderately maternally toxic dose concentrations. In these studies, no evidence of harm to the foetus due to azithromycin was found. There are, however, no adequate and well-controlled studies in pregnant women.</p><p>&nbsp;</p><p>There is a large amount of data from observational studies performed in several countries on exposure to azithromycin during pregnancy, compared to no antibiotic use or use of another antibiotic during the same period (&gt;&nbsp;7,300 first trimester exposures). While most studies do not suggest an association with adverse foetal effects such as major congenital malformations or cardiovascular malformations, there is limited epidemiological evidence of an increased risk of miscarriage following azithromycin exposure in early pregnancy. Therefore, azithromycin should only be used during pregnancy if clinically needed and the benefit of treatment is expected to outweigh any small increased risks which may exist.</p><p>&nbsp;</p><p><u>Breast-feeding</u></p><p>Limited information available from published literature indicates that azithromycin is present in human milk at an estimated highest median daily dose of 0.1 to 0.7 mg/kg/day. No serious adverse effects of azithromycin on the breast-fed infants were observed. A decision must be made whether to discontinue breast-feeding or to discontinue/abstain from azithromycin therapy taking into account the benefit of breast-feeding for the child and the benefit of therapy for the woman.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There is no evidence to suggest that Zithromax may have an effect on a patient&rsquo;s ability to drive or operate machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Zithromax is well tolerated with a low incidence of side effects.</p><p>&nbsp;</p><p>The section below lists the adverse reactions identified through clinical trial experience and postmarketing surveillance by system organ class and frequency. Adverse reactions identified from post-marketing experience are included in italics. The frequency grouping is defined using the following convention: Very common (&ge;&nbsp;1/10); Common (&ge;&nbsp;1/100 to &lt;&nbsp;1/10); Uncommon (&ge;&nbsp;1/1,000 to &lt;&nbsp;1/100); Rare (&ge;&nbsp;1/10,000 to &lt;&nbsp;1/1,000); Very Rare (&lt;&nbsp;1/10,000); and Not known (cannot be estimated from the available data). Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.</p><p>&nbsp;</p><p><strong>Adverse reactions possibly or probably related to azithromycin based on clinical trial experience and post-marketing surveillance:</strong></p><p>&nbsp;</p><p><strong>Infections and Infestations</strong></p><p><strong><em>Uncommon</em></strong><em> (&ge; 1/1,000 to &lt; 1/100)</em></p><p>Candidiasis, oral candidiasis, vaginal infection</p><p><strong><em>Not known</em></strong><em> (cannot be estimated from available data)</em></p><p><em>Pseudomembranous colitis </em>(see section 4.4)<em> </em></p><p>&nbsp;</p><p><strong>Blood and Lymphatic System Disorders </strong></p><p><strong><em>Uncommon</em></strong><em> (&ge; 1/1,000 to &lt; 1/100) </em></p><p>Leukopenia, neutropenia</p><p><strong><em>Not known</em></strong><em> (cannot be estimated from available data)</em></p><p>Thrombocytopenia, haemolytic anaemia</p><p>&nbsp;</p><p><strong>Immune System Disorders</strong></p><p><strong><em>Uncommon</em></strong><em> (&ge; 1/1,000 to &lt; 1/100)</em></p><p>Angioedema, hypersensitivity</p><p><strong><em>Not known</em></strong><em> (cannot be estimated from available data)</em></p><p>Anaphylactic reaction (see section 4.4)</p><p><strong>&nbsp;</strong></p><p><strong>Metabolism and Nutrition Disorders</strong></p><p><strong><em>Common</em></strong><em> (&gt; 1/100 &lt; 1/10) </em></p><p>Anorexia</p><p>&nbsp;</p><p><strong>Psychiatric Disorders </strong></p><p><strong><em>Uncommon</em></strong><em> (&ge; 1/1,000 to &lt; 1/100)</em></p><p>Nervousness</p><p><strong><em>Rare </em></strong><em>(&gt; 1/10,000 &lt; 1/1,000)</em></p><p>Agitation</p><p><strong><em>Not known</em></strong><em> (cannot be estimated from available data)</em></p><p>Aggression, anxiety</p><p>&nbsp;</p><p><strong>Nervous System Disorders </strong></p><p><strong><em>Common </em></strong><em>(&gt; 1/100 &lt; 1/10) </em></p><p>Dizziness, headache, paraesthesia, dysgeusia</p><p><strong><em>Uncommon</em></strong><em> (&ge; 1/1,000 to &lt; 1/100)</em></p><p>Hypoaesethesia, somnolence, insomnia</p><p><strong><em>Not known</em></strong><em> (cannot be estimated from available data)</em></p><p>Syncope, convulsion, psychomotor hyperactivity, anosmia, ageusia, parosmia, <em>Myasthenia gravis</em> (see section 4.4)</p><p>&nbsp;</p><p><strong>Eye Disorders</strong></p><p><strong><em>Common </em></strong><em>(&gt; 1/100 &lt; 1/10) </em></p><p>Visual impairment</p><p>&nbsp;</p><p><strong>Ear and Labyrinth Disorders </strong></p><p><strong><em>Common</em></strong><em> (&gt; 1/100 &lt; 1/10) </em></p><p>Deafness</p><p><strong><em>Uncommon</em></strong><em> (&ge; 1/1,000 to &lt; 1/100)</em></p><p>Hearing impaired, tinnitus</p><p><strong><em>Rare</em></strong><em> (&gt; 1/10,000 &lt; 1/1,000) </em></p><p>Vertigo</p><p>&nbsp;</p><p><strong>Cardiac Disorders</strong></p><p><strong><em>Uncommon</em></strong><em> (&ge; 1/1,000 to &lt; 1/100)</em></p><p>Palpitations</p><p><strong><em>Not known</em></strong><em> (cannot be estimated from available data)</em></p><p><em>Torsades de pointes</em> (see section 4.4), arrhythmia (see section 4.4) including ventricular tachycardia</p><p>&nbsp;</p><p><strong>Vascular Disorders </strong></p><p><strong><em>Not known</em></strong><em> (cannot be estimated from available data)</em></p><p>Hypotension</p><p>&nbsp;</p><p><strong>Gastrointestinal Disorders </strong></p><p><strong><em>Very common</em></strong><em> (&ge; 1/10)</em></p><p>Diarrhoea, abdominal pain, nausea, flatulence</p><p><strong><em>Common</em></strong><em> (&gt; 1/100 &lt; 1/10) </em></p><p>Vomiting, dyspepsia</p><p><strong><em>Uncommon</em></strong><em> (&gt; 1/1,000 &lt; 1/100) </em></p><p>Gastritis, constipation</p><p><strong><em>Not known</em></strong><em> (cannot be estimated from available data)</em></p><p>Pancreatitis, tongue discolouration</p><p>&nbsp;</p><p><strong>Hepatobiliary Disorders </strong></p><p><strong><em>Uncommon</em></strong><em> (&gt; 1/1,000 &lt; 1/100)</em></p><p>Hepatitis</p><p><strong><em>Rare</em></strong><em> (&gt; 1/10,000 &lt; 1/1,000) </em></p><p>Hepatic function abnormal</p><p><strong><em>Not known</em></strong><em> (cannot be estimated from available data)</em></p><p>Hepatic failure (see section 4.4), which has rarely resulted in death, hepatitis fulminant, hepatic necrosis, jaundice cholestatic</p><p>&nbsp;</p><p><strong>Skin and Subcutaneous Tissue Disorders </strong></p><p><strong><em>Common</em></strong><em> (&gt; 1/100 &lt; 1/10) </em></p><p>Pruritus and rash</p><p><strong><em>Uncommon</em></strong><em> (&gt; 1/1,000 &lt; 1/100)</em></p><p>SJS, photosensitivity reaction, urticaria</p><p><strong><em>Rare</em></strong><strong> </strong><em>(&ge; 1/10,000 to &lt; 1/1,000)</em></p><p>Acute Generalized Exanthematous Pustulosis (AGEP)<sup>*&sect;</sup></p><p>Drug reaction with eosinophilia and systemic symptoms (DRESS)<sup>*&sect;</sup></p><p><strong><em>Not known</em></strong><em> (cannot be estimated from available data)</em></p><p>TEN, erythema multiforme</p><p>&nbsp;</p><p><strong>Musculoskeletal, Connective Tissue Disorders </strong></p><p><strong><em>Common</em></strong><em> (&gt; 1/100 &lt; 1/10) </em></p><p>Arthralgia</p><p>&nbsp;</p><p><strong>Renal and Urinary Disorders </strong></p><p><strong><em>Not known</em></strong><em> (cannot be estimated from available data)</em></p><p>Renal failure acute, nephritis interstitial</p><p>&nbsp;</p><p><strong>General disorders and Administration Site Conditions</strong></p><p><strong><em>Common</em></strong><em> (&gt; 1/100 &lt; 1/10) </em></p><p>Fatigue</p><p><strong><em>Uncommon</em></strong><em> (&gt; 1/1,000 &lt; 1/100)</em></p><p>Chest pain, oedema, malaise, asthenia</p><p>&nbsp;</p><p><strong>Investigations</strong></p><p><strong><em>Common</em></strong><em> (&gt; 1/100 &lt; 1/10) </em></p><p>Lymphocyte count decreased, eosinophil count increased, blood bicarbonate decreased</p><p><strong><em>Uncommon</em></strong><em> (&gt; 1/1,000 &lt; 1/100)</em></p><p>Aspartate aminotransferase increased, alanine aminotransferase increased, blood bilirubin increased, blood urea increased, blood creatinine increased, blood potassium abnormal</p><p><strong><em>Not known </em></strong><em>(cannot be estimated from available data)</em></p><p>Electrocardiogram QT prolonged (see section 4.4)</p><p>&nbsp;</p><p>*ADR identified post-marketing</p><p><sup>&sect;</sup>ADR frequency represented by the estimated upper limit of the 95% confidence interval calculated using the &ldquo;Rule of 3&rdquo;.</p><p>&nbsp;</p><p><u>Reporting of suspected adverse reactions</u></p><p>Reporting suspected adverse reactions after&nbsp;marketing&nbsp;authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions&nbsp;according to their local country requirements.</p><p>&nbsp;</p><p>To Report side effects</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Saudi</strong><strong> Arabia</strong></p><p><strong>&nbsp;</strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>National Pharmacovigilance Centre (NPC)</strong></p><ul><li>Call center: 19999</li><li>E-mail: npc.drug@sfda.gov.sa</li><li>Website: https://ade.sfda.gov.sa/&nbsp;&nbsp;</li></ul></td></tr></tbody></table><p><strong>&nbsp;</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Other GCC States</strong></p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>-&nbsp;&nbsp; <em>Please contact the relevant competent authority.</em></p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Adverse events experienced in higher than recommended doses were similar to those seen at normal doses. The typical symptoms of an overdose with macrolide antibiotics include reversible loss of hearing, severe nausea, vomiting and diarrhoea. In the event of overdose, the administration of medicinal charcoal and general symptomatic treatment and supportive measures are indicated as required.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><em>General properties </em></strong></p><p>Pharmacotherapeutic group: Antibacterials for systemic use. ATC code: J01FA10</p><p>&nbsp;</p><p><u>Mode of action</u></p><p>Zithromax is a macrolide antibiotic belonging to the azalide group. The molecule is constructed by adding a nitrogen atom to the lactone ring of erythromycin A. The chemical name of azithromycin is 9-deoxy-9a-aza-9a-methyl-9a-homoerythromycin A. The molecular weight is 749.0. The mechanism of action of azithromycin is based upon the suppression of bacterial protein synthesis by means of binding to the ribosomal 50S sub-unit and inhibition of peptide translocation.</p><p>&nbsp;</p><p><u>Mechanism of resistance</u></p><p>Resistance to azithromycin may be inherent or acquired. There are three main mechanisms of resistance in bacteria: target site alteration, alteration in antibiotic transport and modification of the antibiotic.</p><p>&nbsp;</p><p>Azithromycin demonstrates cross resistance with erythromycin resistant gram positive isolates. A decrease in macrolide susceptibility over time has been noted particularly in Streptococcus pneumoniae and Staphylococcus aureus. Similarly, decreased susceptibility has been observed among Streptococcus viridans and Streptococcus agalactiae (Group B) streptococcus against other macrolides and lincosamides.</p><p>&nbsp;</p><p><strong><em>Breakpoints </em></strong></p><p>Azithromycin susceptibility breakpoints for typical bacterial pathogens published by EUCAST are:</p><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td rowspan="2" style="vertical-align:top"><p><strong>Organism</strong></p></td><td colspan="2" style="vertical-align:top"><p><strong>MIC breakpoints (mg/L)</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Susceptible (S&le;)</strong></p></td><td style="vertical-align:top"><p><strong>Resistant (R&gt;)</strong></p></td></tr><tr><td style="vertical-align:top"><p><em>Staphylococcus</em> spp.</p></td><td style="vertical-align:top"><p>1</p></td><td style="vertical-align:top"><p>2</p></td></tr><tr><td style="vertical-align:top"><p><em>Streptococcus</em> groups A, B, C and G</p></td><td style="vertical-align:top"><p>0.25</p></td><td style="vertical-align:top"><p>0.5</p></td></tr><tr><td style="vertical-align:top"><p><em>Streptococcus pneumoniae</em></p></td><td style="vertical-align:top"><p>0.25</p></td><td style="vertical-align:top"><p>0.5</p></td></tr><tr><td style="vertical-align:top"><p><em>Haemophilus influenzae</em></p></td><td style="vertical-align:top"><p>0.12</p></td><td style="vertical-align:top"><p>4</p></td></tr><tr><td style="vertical-align:top"><p><em>Moraxella catarrhalis</em></p></td><td style="vertical-align:top"><p>0.25</p></td><td style="vertical-align:top"><p>0.5</p></td></tr><tr><td style="vertical-align:top"><p><em>Neisseria gonorrhoeae</em></p></td><td style="vertical-align:top"><p>0.25</p></td><td style="vertical-align:top"><p>0.5</p></td></tr></tbody></table><p>&nbsp;</p><p><strong><em>Susceptibility </em></strong></p><p>The prevalence of acquired resistance may vary geographically and with time for selected species and local information on resistance is desirable, particularly when treating severe infections. As necessary, expert advice should be sought when the local prevalence of resistance is such that the utility of the agent in at least some types of infections is questionable.</p><p>&nbsp;</p><p>Table: Antibacterial spectrum of Azithromycin</p><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>Commonly susceptible species </strong></p><p><strong>&nbsp;</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Aerobic Gram-positive microorganisms </strong></p></td></tr><tr><td style="vertical-align:top"><p><em>Staphylococcus aureus </em></p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Methycillin-susceptible</p></td></tr><tr><td style="vertical-align:top"><p><em>Streptococcus pneumoniae </em></p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Penicillin-susceptible</p></td></tr><tr><td style="vertical-align:top"><p><em>Streptococcus pyogenes </em><strong>(Group A) </strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Aerobic Gram-negative microorganisms </strong></p></td></tr><tr><td style="vertical-align:top"><p><em>Haemophilus influenzae </em></p><p><em>Haemophilus parainfluenzae </em></p></td></tr><tr><td style="vertical-align:top"><p><em>Legionella pneumophila </em></p></td></tr><tr><td style="vertical-align:top"><p><em>Moraxella catarrhalis </em></p></td></tr><tr><td style="vertical-align:top"><p><em>Neisseria gonorrhoeae</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Pasteurella multocida </em></p></td></tr><tr><td style="vertical-align:top"><p><strong>Anaerobic microorganisms </strong></p></td></tr><tr><td style="vertical-align:top"><p><em>Clostridium perfringens </em></p></td></tr><tr><td style="vertical-align:top"><p><em>Fusobacterium spp. </em></p></td></tr><tr><td style="vertical-align:top"><p><em>Prevotella spp. </em></p></td></tr><tr><td style="vertical-align:top"><p><em>Porphyromonas spp. </em></p></td></tr><tr><td style="vertical-align:top"><p><strong>Other microorganisms </strong></p></td></tr><tr><td style="vertical-align:top"><p><em>Chlamydia trachomatis </em></p></td></tr><tr><td style="vertical-align:top"><p><strong>Species for which acquired resistance may be a problem </strong></p><p><strong>&nbsp;</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Aerobic Gram-positive microorganisms </strong></p></td></tr><tr><td style="vertical-align:top"><p><em>Streptococcus pneumoniae </em></p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Penicillin-intermediate</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Penicillin-resistant</p></td></tr><tr><td style="vertical-align:top"><p><strong>Inherently resistant organisms </strong></p><p><strong>&nbsp;</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Aerobic Gram-positive microorganisms </strong></p></td></tr><tr><td style="vertical-align:top"><p><em>Enterococcus faecalis </em></p></td></tr><tr><td style="vertical-align:top"><p>Staphylococci <strong>MRSA, MRSE</strong>*</p></td></tr><tr><td style="vertical-align:top"><p><strong>Anaerobic microorganisms </strong></p></td></tr><tr><td style="vertical-align:top"><p>Bacteroides fragilis group</p></td></tr></tbody></table><p>&nbsp;</p><p>* Methycillin-resistant staphylococci have a very high prevalence of acquired resistance to macrolides and have been placed here because they are rarely susceptible to azithromycin.</p><p>&nbsp;</p><p><u>Paediatric population</u></p><p>Following the assessment of studies conducted in children, the use of azithromycin is not recommended for the treatment of malaria, neither as monotherapy nor combined with chloroquine or artemisinin based drugs, as non-inferiority to anti-malarial drugs recommended in the treatment of uncomplicated malaria was not established.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Absorption </u></p><p>Bioavailability after oral administration is approximately 37%. Peak plasma concentrations are attained 2&nbsp;to 3 hours after taking the medicinal product.</p><p>&nbsp;</p><p><u>Distribution </u></p><p>Orally administered azithromycin is widely distributed throughout the body. In pharmacokinetic studies it has been demonstrated that the concentrations of azithromycin measured in tissues are noticeably higher (as much as 50 times) than those measured in plasma, which indicates that the agent strongly binds to tissues.</p><p>&nbsp;</p><p>Binding to serum proteins varies according to plasma concentration and ranges from 12% at 0.5&nbsp;microgram/ml up to 52% at 0.05 microgram azithromycin/ml serum. The mean volume of distribution at steady state (VVss) has been calculated to be 31.1 l/kg.</p><p>&nbsp;</p><p><u>Elimination </u></p><p>The terminal plasma elimination half-life closely reflects the elimination half-life from tissues of 2 to 4&nbsp;days.</p><p>&nbsp;</p><p>Approximately 12% of an intravenously administered dose of azithromycin is excreted unchanged in urine within the following three days. Particularly high concentrations of unchanged azithromycin have been found in human bile. Also in bile, ten metabolites were detected, which were formed through N- and O- demethylation, hydroxylation of desosamine and aglycone rings and cleavage of cladinose conjugate. Comparison of the results of liquid chromatography and microbiological analyses has shown that the metabolites of azithromycin are not microbiologically active.</p><p>&nbsp;</p><p>In animal tests, high concentrations of azithromycin have been found in phagocytes. It has also been established that during active phagocytosis higher concentrations of azithromycin are released from inactive phagocytes. In animal models this results in high concentrations of azithromycin being delivered to the site of infection.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Phospholipidosis (intracellular phospholipid accumulation) has been observed in several tissues (e.g. eye, dorsal root ganglia, liver, gallbladder, kidney, spleen, and/or pancreas) of mice, rats, and dogs given multiple doses of azithromycin. Phospholipidosis has been observed to a similar extent in the tissues of neonatal rats and dogs. The effect has been shown to be reversible after cessation of azithromycin treatment. The significance of the finding for animals and humans is unknown.</p><p>&nbsp;</p><p><u>Carcinogenic potential</u></p><p>Long-term studies in animals have not been performed to evaluate carcinogenic potential as the drug is indicated for short-term treatment only and there were no signs indicative of carcinogenic activity.</p><p>&nbsp;</p><p><u>Mutagenic potential</u></p><p>There was no evidence of a potential for genetic and chromosome mutations in in-vivo and in-vitro test models.</p><p>&nbsp;</p><p><u>Reproductive toxicity</u></p><p>In animal studies for embryotoxic effects of the substance, no teratogenic effect was observed in mice and rats. In rats, azithromycin doses of 100 and 200 mg/kg bodyweight/day led to mild retardation of foetal ossification and in maternal weight gain. In peri- and postnatal studies in rats, mild retardation following treatment with 50 mg/kg/day azithromycin and above was observed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Hydroxypropylcellulose</p><p>Sodium phosphate tribasic anhydrous</p><p>Sucrose</p><p>Xanthan gum</p><p>Flavours:</p><p>Artificial banana</p><p>Artificial cherry</p><p>Artificial creme de vanilla.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Do not use Zithromax Powder for Oral Suspension after the expiry date which is stated on the carton / Bottle label after EXP:. 

24 months.   

Once reconstituted with water, Zithromax Suspension has a shelf-life of 5 days. 

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30&deg;C.</p><p>After reconstitution, the oral suspension is stable for 5 days when stored below 30&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Zithromax Powder for Oral Suspension is available as:</p><p>&nbsp;</p><p>600 mg (15 ml) Pack: (Recommended for use in children up to 7 years (25 kg)).</p><p>Packs of powder equivalent to 600 mg azithromycin in a polypropylene container with child resistant screw cap (with or without a tamper evident seal), in a carton box. Pack contains a double-ended multi-dosing spoon<sup>1</sup> and 10 ml oral dosing syringe with detachable adaptor. Reconstitute with 9 ml of water to give 15 ml suspension.</p><p>&nbsp;</p><p>900 mg (22.5 ml) Pack: (Recommended for use in children aged from 8-11 years (26-35 kg)).</p><p>Packs of powder equivalent to 900 mg azithromycin in a polypropylene container with child resistant screw cap (with or without a tamper evident seal), in a carton box. Pack contains a double-ended multi-dosing spoon<sup>1</sup>. Reconstitute with 12 ml of water to give 22.5 ml suspension.</p><p>&nbsp;</p><p>1200 mg (30 ml) Pack: (Recommended for use in children aged from 12-14 years (36-45 kg)).</p><p>Packs of powder equivalent to 1200 mg azithromycin in a polypropylene container with child resistant screw cap (with or without a tamper evident seal) in a carton box. Pack contains a double-ended multi-dosing spoon<sup>1</sup>. Reconstitute with 15 ml of water to give 30 ml suspension.</p><p>&nbsp;</p><p><sup>1 </sup>Multi-dosing spoon delivers doses as follows:</p><p>&nbsp;</p><p>Small end to graduation&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2.5 ml (100 mg)</p><p>brimful&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5 ml (200 mg)</p><p>Large end to graduation&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7.5 ml (300 mg)</p><p>brimful&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10 ml (400 mg)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Keep out of the sight and reach of children.</p><p>&nbsp;</p><p>When dispensing the 15 ml pack, advice should be given as to whether the dose should be measured using the oral dosing syringe or the spoon provided and on correct usage. If the dose is to be given using the oral dosing syringe, before dispensing the syringe adaptor should be detached from the syringe and inserted into the bottle neck and the cap replaced.</p><p>&nbsp;</p><p>When dispensing 22.5 ml, or 30 ml packs, advice should be given as to the correct usage of the multi-dosing spoon.</p><p>&nbsp;</p><p>Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p><p>&nbsp;</p><p>Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                MARKETING AUTHORISATION HOLDER
Pfizer Saudi Limited – Saudi Arabia 

MANUFACTURER
Pfizer Saudi Limited, Saudi Arabia

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                August 2023
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>